Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Gentile

Showing results (21-30 of 313) with videos related to

Pageof 32
Sort By:
Antiviral Therapy|September 6, 2002
Selection of a T-cell line resistant to stavudine and zidovudine by prolonged treatment with stavudineOmbretta Turriziani, Carolina Scagnolari, Federica Bambacioni, et al.
International Journal of Hematology|July 28, 2014
A prognostic algorithm including a modified version of MD Anderson Cancer Center (MDACC) score predicts time to first treatment of patients with clinical monoclonal lymphocytosis (cMBL)/Rai stage 0 chronic lymphocytic leukemia (CLL)Stefano Molica, Diana Giannarelli, Luciano Levato, et al.
Expert Opinion on Investigational Drugs|April 8, 2011
How to treat patients with relapsed/refractory multiple myeloma: evidence-based information and opinionsMassimo Offidani, Laura Corvatta, Fortunato Morabito, et al.
Expert Review of Hematology|September 2, 2014
Changes in the incidence, pattern of presentation and clinical outcome of early chronic lymphocytic leukemia patients using the 2008 International Workshop on CLL guidelinesStefano Molica, Diana Giannarelli, Rosanna Mirabelli, et al.
Journal of Molecular Biology|January 24, 2007
Mutation in the VP1-LDV motif of the murine polyomavirus affects viral infectivity and conditions virus tissue tropism in vivoMaddalena Caruso, Anna Busanello, Olga Sthandier, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 30, 2020
Detection of SARS-COV N2 Gene: Very low amounts of viral RNA or false positive?Francesca Falasca, Ilaria Sciandra, Daniele Di Carlo, et al.
European Journal of Haematology|June 19, 2015
Bendamustine in multiple myelomaMassimo Gentile, Ernesto Vigna, Anna Grazia Recchia, et al.
Antioxidants (Basel, Switzerland)|January 28, 2026
OPA1 as a Cancer Target: Molecular Mechanisms, Structural Insights, and Strategies for Drug DevelopmentAntonio Curcio, Ludovica Ganino, Ilenia Valentino, et al.
European Journal of Haematology|March 31, 2015
Unavailability of thymidine kinase does not preclude the use of German comprehensive prognostic index: results of an external validation analysis in early chronic lymphocytic leukemia and comparison with MD Anderson Cancer Center modelStefano Molica, Diana Giannarelli, Rosanna Mirabelli, et al.
Pharmaceuticals (Basel, Switzerland)|September 27, 2025
Discovery of a Promising Hydroxyamino-Piperidine HDAC6 Inhibitor via Integrated Virtual Screening and Experimental Validation in Multiple MyelomaFederica Chiera, Antonio Curcio, Roberta Rocca, et al.
Pageof 32

Showing results (21-30 of 313) with videos related to

Sort By:
Pageof 32
Antiviral Therapy|September 6, 2002
Selection of a T-cell line resistant to stavudine and zidovudine by prolonged treatment with stavudineOmbretta Turriziani, Carolina Scagnolari, Federica Bambacioni, et al.
International Journal of Hematology|July 28, 2014
A prognostic algorithm including a modified version of MD Anderson Cancer Center (MDACC) score predicts time to first treatment of patients with clinical monoclonal lymphocytosis (cMBL)/Rai stage 0 chronic lymphocytic leukemia (CLL)Stefano Molica, Diana Giannarelli, Luciano Levato, et al.
Expert Opinion on Investigational Drugs|April 8, 2011
How to treat patients with relapsed/refractory multiple myeloma: evidence-based information and opinionsMassimo Offidani, Laura Corvatta, Fortunato Morabito, et al.
Expert Review of Hematology|September 2, 2014
Changes in the incidence, pattern of presentation and clinical outcome of early chronic lymphocytic leukemia patients using the 2008 International Workshop on CLL guidelinesStefano Molica, Diana Giannarelli, Rosanna Mirabelli, et al.
Journal of Molecular Biology|January 24, 2007
Mutation in the VP1-LDV motif of the murine polyomavirus affects viral infectivity and conditions virus tissue tropism in vivoMaddalena Caruso, Anna Busanello, Olga Sthandier, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 30, 2020
Detection of SARS-COV N2 Gene: Very low amounts of viral RNA or false positive?Francesca Falasca, Ilaria Sciandra, Daniele Di Carlo, et al.
European Journal of Haematology|June 19, 2015
Bendamustine in multiple myelomaMassimo Gentile, Ernesto Vigna, Anna Grazia Recchia, et al.
Antioxidants (Basel, Switzerland)|January 28, 2026
OPA1 as a Cancer Target: Molecular Mechanisms, Structural Insights, and Strategies for Drug DevelopmentAntonio Curcio, Ludovica Ganino, Ilenia Valentino, et al.
European Journal of Haematology|March 31, 2015
Unavailability of thymidine kinase does not preclude the use of German comprehensive prognostic index: results of an external validation analysis in early chronic lymphocytic leukemia and comparison with MD Anderson Cancer Center modelStefano Molica, Diana Giannarelli, Rosanna Mirabelli, et al.
Pharmaceuticals (Basel, Switzerland)|September 27, 2025
Discovery of a Promising Hydroxyamino-Piperidine HDAC6 Inhibitor via Integrated Virtual Screening and Experimental Validation in Multiple MyelomaFederica Chiera, Antonio Curcio, Roberta Rocca, et al.
Pageof 32